Addressing the Incidence of MDR-TB in India and Globally: Insights from Dr. Sameer Deepak Lote

Join Dr. Sameer Deepak Lote, an expert in infectious diseases, as he sheds light on the urgent issue of drug resistant tuberculosis on this World TB Day. With a focus on MDR TB, Dr. Lote discusses the challenges posed by multi drug resistance in TB and the critical need for effective MDR TB treatment.

Drug resistant tuberculosis is a growing concern, affecting approximately 465,000 individuals globally, with around 150,000 cases in India alone. In this video, learn how Next-Generation Sequencing (NGS) is revolutionizing the diagnosis and management of drug resistant TB, allowing for faster and more precise treatment options tailored to individual patients.

Discover the implications of MDR TB and the importance of rapid diagnostic tools in combating this public health threat. Don’t miss this insightful discussion with Dr. Lote, who highlights the path forward in the fight against multi drug resistance in TB.
Together, we can raise awareness and contribute to the global efforts to eliminate drug resistant tuberculosis. Watch now to find out how you can help!

---------------------------------------------

▬⏰⏰ Contents of this video ⏰⏰ ▬▬

0:00 – Introduction
0:13 – Understanding MDR Tuberculosis
0:18 – Definition and Impact of MDR TB
0:24 – Challenges with First-Line Drugs
0:30 – The Need for Second-Line Drugs
0:35 – Global and Indian Statistics on MDR TB
0:43 – The Importance of Rapid Diagnostic Tools
0:47 – How Next-Generation Sequencing (NGS) Helps
0:51 – Rapid Diagnosis and Drug Resistance Detection
1:02 – Tailored Management for MDR TB Patients
1:10 – Long Treatment Duration for MDR and XDR TB
1:15 – The Paradigm Shift in TB Management
1:22 – NGS as the Future Gold Standard
1:30 – Conclusion

---------------------------------------------
🩺Book a Free Genetic Counseling session with our experts here: https://diagnostics.medgenome.com/

✅Explore Our Resources:
Blogs: https://diagnostics.medgenome.com/blog/
Patient Stories: https://diagnostics.medgenome.com/pat...
Press Media Mentions: https://diagnostics.medgenome.com/press/

👍Follow and Like us on:
Instagram:   / medgenome  
Facebook:   / medgenomelabs  
Twitter: https://x.com/medgenomelabs
LinkedIn:   / medgenomelabs  

🤝Connect With Us:

Email: [email protected]
Toll-free number: 1800 296 9696

⬇️Download Our Application:

Android: https://bit.ly/3yYVvAb
iOS: https://bit.ly/4cxRikU

#MDRTB #DrugResistantTB #Tuberculosis #NextGenerationSequencing #TBManagement #GlobalHealth #AntibioticResistance #PrecisionMedicine #RapidDiagnostics #HealthcareInnovation #TBElimination
---------------------------------------------
About MedGenome

MedGenome is a global leader in genetic testing services, genomics research, and drug discovery solutions. Since 2013, we have been committed to delivering world-class genomic solutions with precision and accuracy, empowering every individual to manage their health better.

We are proud to be the only CAP-accredited genetic testing lab in India, offering 1300+ genetic tests backed by the latest and most advanced technologies available worldwide. MedGenome is dedicated to providing the best precision testing solutions for quicker and smarter diagnosis of complex diseases.

Our Mission

We are on a mission to democratize access to quality and affordable genetic solutions, serving over 4 billion people for their healthcare needs through the power of genetic testing.

Our Expertise

We operate Southeast Asia's largest CAP-accredited Next Generation Sequencing (NGS) lab, equipped with cutting-edge genome sequencing platforms such as Illumina’s NovaSeq, HiSeq X, MiSeq, and more. Our team consists of expert molecular biologists, geneticists, data scientists, and bioinformaticians driving our genomics research.

As a firm believer in quality, MedGenome adheres to the highest international standards in our services and has obtained the prestigious CAP accreditation for our main lab in Bangalore.

At MedGenome, we continue to push the boundaries of genetic research, providing insights into complex diseases and driving innovation in personalized medicine.
---------------------------------------------
Disclaimer:

The content provided in this video is intended solely for educational purposes. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. If you have any concerns, please consult a qualified healthcare provider. MedGenome accepts no liability for individual interpretations of the content, although it is accurate to the best of our knowledge at the time of publication.